KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Medpace Holdings (MEDP) Return on Invested Capital (2016 - 2025)

Medpace Holdings' Return on Invested Capital history spans 10 years, with the latest figure at 1.18% for Q4 2025.

  • For Q4 2025, Return on Invested Capital rose 74.0% year-over-year to 1.18%; the TTM value through Dec 2025 reached 1.18%, up 74.0%, while the annual FY2025 figure was 0.69%, 14.0% up from the prior year.
  • Return on Invested Capital reached 1.18% in Q4 2025 per MEDP's latest filing, down from 1.81% in the prior quarter.
  • In the past five years, Return on Invested Capital ranged from a high of 1.81% in Q3 2025 to a low of 0.19% in Q1 2021.
  • Average Return on Invested Capital over 5 years is 0.56%, with a median of 0.48% recorded in 2024.
  • Peak YoY movement for Return on Invested Capital: fell -19bps in 2024, then skyrocketed 139bps in 2025.
  • A 5-year view of Return on Invested Capital shows it stood at 0.19% in 2021, then skyrocketed by 170bps to 0.52% in 2022, then grew by 6bps to 0.55% in 2023, then decreased by -19bps to 0.44% in 2024, then skyrocketed by 166bps to 1.18% in 2025.
  • Per Business Quant, the three most recent readings for MEDP's Return on Invested Capital are 1.18% (Q4 2025), 1.81% (Q3 2025), and 1.05% (Q2 2025).